Diabetes mellitus, race and the odds of high grade prostate cancer in men treated with radiation therapy

Journal of Urology

Volumn 186, Issue 6, 2011, Pages 2233-2238

  Mitin, Timur ^a,b,c,d   Chen, Ming Hui ^a,b,c,d   Zhang, Yuanye ^a,b,c,d   Moran, Brian J ^a,b,c,d   Dosoretz, Daniel E ^a,b,c,d   Katin, Michael J ^a,b,c,d   Braccioforte, Michelle H ^a,b,c,d   Salenius, Sharon A ^a,b,c,d   D'Amico, Anthony V ^a,b,c,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c Prostate Cancer Foundation of Chicago   (United States)

^d 21ST CENTURY ONCOLOGY   (United States)

Author keywords

African Americans; diabetes mellitus; prostate; prostatic neoplasms; risk

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RISK; COHORT ANALYSIS; DIABETES MELLITUS; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RACE;

EID: 80755169582     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.07.072     Document Type: Article

References (27)

1. P.C. Walsh, T.L. DeWeese, and M.A. Eisenberger Clinical practice Localized prostate cancer N Engl J Med 357 2007 2696
2. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969
3. M.V. Pilepich, J.M. Krall, and W.T. Sause Prognostic factors in carcinoma of the prostateanalysis of RTOG study 75-06 Int J Radiat Oncol Biol Phys 13 1987 339
4. O. Andren, K. Fall, and L. Franzen How well does the Gleason score predict prostate cancer death? A 20-year followup of a population based cohort in Sweden J Urol 175 2006 1337
5. S.F. Altekruse, C.L. Kosary, and M. Krapcho SEER Cancer Statistics Review, 19752007 Bethesda: National Cancer Institute http://seer.cancer.gov/csr/ 1975-2007/ based on November 2009 SEER data submission. Posted to the SEER web site 2010
6. C.K. Cross, D. Shultz, and S.B. Malkowicz Impact of race on prostate-specific antigen outcome after radical prostatectomy for clinically localized adenocarcinoma of the prostate J Clin Oncol 20 2002 2863
7. M.E. Nielsen, M. Han, and L. Mangold Black race does not independently predict adverse outcome following radical retropubic prostatectomy at a tertiary referral center J Urol 176 2006 515
8. Age-Adjusted Incidence of Diagnosed Diabetes per 1,000 Population Aged 1879 Years, by Race/Ethnicity, United States, 19972008 Centers for Disease Control and Prevention http://www.cdc.gov/diabetes/statistics/incidence/fig6.htm Accessed August 18, 2010
9. C.C. Cowie, F.K. Port, and R.A. Wolfe Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes N Engl J Med 321 1989 1074
10. M.I. Harris, R. Klein, and C.C. Cowie Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A US population study Diabetes Care 21 1998 1230
11. L.A. Lavery, H.R. Ashry, and W. van Houtum Variation in the incidence and proportion of diabetes-related amputations in minorities Diabetes Care 19 1996 48
12. J.A. Pugh, M.P. Stern, and S.M. Haffner Excess incidence of treatment of end-stage renal disease in Mexican Americans Am J Epidemiol 127 1988 135
13. J.S. Kasper, and E. Giovannucci A meta-analysis of diabetes mellitus and the risk of prostate cancer Cancer Epidemiol Biomarkers Prev 15 2006 2056
14. S. Bonovas, K. Filioussi, and A. Tsantes Diabetes mellitus and risk of prostate cancer: a meta-analysis Diabetologia 47 2004 1071
15. A.V. D'Amico, M.H. Braccioforte, and B.J. Moran Causes of death in men with prevalent diabetes and newly diagnosed high- versus favorable-risk prostate cancer Int J Radiat Oncol Biol Phys 77 2010 1329
16. J. Jayachandran, W.J. Aronson, and M.K. Terris Diabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the Shared Equal Access Regional Cancer Hospital database Cancer Epidemiol Biomarkers Prev 19 2010 9
17. A. Agresti Categorical Data Analysis 2nd ed. 2002 John Wiley and Sons New York 165 210
18. M. Hollander, and D.A. Wolfe Nonparametric Statistical Methods 1999 John Wiley and Sons New York 106 140
19. F. Abdollah, A. Briganti, and N. Suardi Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? Prostate Cancer Prostatic Dis 14 2011 74
20. M.F. Leitzmann, J. Ahn, and D. Albanes Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Cancer Causes Control 19 2008 1267
21. S.K. Hong, J.J. Oh, and S.S. Byun Impact of diabetes mellitus on the detection of prostate cancer via contemporary multi (>/=12)-core prostate biopsy Prostate 2011 Epub ahead of print
22. Y.H. Shao, K. Demissie, and W. Shih Contemporary risk profile of prostate cancer in the United States J Natl Cancer Inst 101 2009 1280
23. J.W. Moul, I.A. Sesterhenn, and R.R. Connelly Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men JAMA 274 1995 1277
24. N. Baradaran, H. Ahmadi, and S. Salem The protective effect of diabetes mellitus against prostate cancer: role of sex hormones Prostate 69 2009 1744
25. S.M. Harman, E.J. Metter, and J.D. Tobin Longitudinal effects of aging on serum total and free testosterone levels in healthy men Baltimore Longitudinal Study of Aging J Clin Endocrinol Metab 86 2001 724
26. S. Yamamoto, J. Yonese, and S. Kawakami Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy Eur Urol 52 2007 696
27. E. Xylinas, G. Ploussard, and X. Durand Low pretreatment total testosterone (<3 ng/mL) predicts extraprostatic disease in prostatectomy specimens from patients with preoperative localized prostate cancer BJU Int 107 2011 1400